Tryp Therapeutics Inc (TRYPF) Corporate Presentation

Corporate Presentation Fall 2021 OUR SOLUTIONS: TRP-8802 (ORAL SYNTHETIC PSILOCYBIN) TRP-8802 is a non-proprietary 25 mg oral capsule of synthetic psilocybin sourced from Usona Institute. 14 Using TRPՓ8802 for our Phase 2a studies allows us to quickly initiate our clinical trials as we determine the effectiveness of psilocybin for our target indications.